Skip to main content
PeptiDex - Peptide Research and Education Platform
PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Research Disclaimer

All information on PeptiDex is for educational and research purposes only. None of the compounds discussed are FDA-approved for human consumption unless explicitly noted (e.g., Semaglutide under prescription). Always consult a qualified medical professional before considering any peptide protocol. The vendors listed operate as raw chemical and laboratory supply companies. Their products are intended solely for authorized laboratory, educational, and research purposes. PeptiDex does not sell, distribute, or endorse any compound for human or animal use.

PeptiDex

The independent, evidence-based peptide research index. Trusted by researchers worldwide.

Learn & Research

  • Peptide 101 Hub
  • Peptide Library
  • Evidence Dashboard
  • Research Blog
  • FAQ

Compare & Source

  • Vendor Reviews
  • Price Comparison
  • Compare Tool
  • Cycle Planner
  • Community Stacks

Recent Articles

  • Tesamorelin: What Sets It Apart from Every Other Growth Hormone Peptide
  • Peptide Stacking in 2026: Why Combination Protocols Are Redefining Results
  • The 2026 FDA Peptide Reclassification: What It Means for Patients, Providers, and the Future of Peptide Therapy

© 2026 PeptiDex. All rights reserved.

About UsEditorial PolicyMedical DisclaimerPrivacy & Terms
Home
LibraryBlogStartToolsSaved
All Blends
💉

CJC-1295 / Ipamorelin / GHRP-6

"The Triple GH Amplifier"

CJC-1295IpamorelinGHRP-6Growth Hormone

Benefits

Maximum GH output, muscle hypertrophy, accelerated fat loss, appetite stimulation

Why This Blend?

Combines three GH pathways: CJC-1295 for sustained GHRH, Ipamorelin for clean GH pulses, and GHRP-6 for powerful ghrelin-mimetic action with appetite stimulation — ideal for those seeking maximum growth.

Mechanism of Action

Triple-axis GH stimulation via GHRH receptor (CJC-1295), GHS receptor selective (Ipamorelin), and GHS receptor with ghrelin-like appetite effects (GHRP-6). Creates the most potent non-HGH growth hormone response.

Dosing Protocol

Typical Ratio: CJC-1295 1000mcg + Ipamorelin 200mcg + GHRP-6 100mcg

Inject SubQ pre-bed or morning fasted. GHRP-6 adds hunger — useful for bulking. Cycle 8-16 weeks. More advanced protocol.

Expected Timeline

Week 1

Pronounced GH flush; increased appetite from GHRP-6; deeper sleep

Weeks 2–4

Rapid recovery; early lean mass gains; noticeable hunger increase

Months 2–3

Significant body recomposition; elevated IGF-1; muscle fullness

Long-term

Maximum non-HGH body composition optimization; monitor bloodwork

Supporting Studies

CJC-1295 preserves pulsatile GH secretion

7.5-fold increase in basal GH while preserving natural pulsatile pattern.

moderate

Ipamorelin PK/PD in healthy volunteers

Dose-escalation study showing single-episode GH release.

moderate

Safety Notes

More aggressive than CJC/Ipa alone. GHRP-6 increases appetite and may raise cortisol slightly. Monitor blood glucose. Not FDA-approved.

📚 Individual Peptide Profiles

CJC-1295 →Ipamorelin →GHRP-6 →